Goldman Sachs Group Valuation
Is GS * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of GS * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: GS * (MX$7321.5) is trading above our estimate of fair value (MX$4080.88)
Significantly Below Fair Value: GS * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for GS *?
Other financial metrics that can be useful for relative valuation.
| What is GS *'s n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$146.61b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | 1.2x |
Price to Earnings Ratio vs Peers
How does GS *'s PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 28.5x | ||
VALUEGF O Value Grupo Financiero. de | 58.2x | n/a | Mex$14.9b |
ACTINVR B Corporación Actinver S. A. B. de C. V | 7.7x | 12.7% | Mex$8.1b |
MS Morgan Stanley | 16.7x | 10.3% | US$151.0b |
SCHW Charles Schwab | 31.2x | 16.4% | US$137.0b |
GS * Goldman Sachs Group | 17x | 13.6% | Mex$146.6b |
Price-To-Earnings vs Peers: GS * is good value based on its Price-To-Earnings Ratio (17x) compared to the peer average (28.5x).
Price to Earnings Ratio vs Industry
How does GS *'s PE Ratio compare vs other companies in the South American Capital Markets Industry?
Price-To-Earnings vs Industry: GS * is expensive based on its Price-To-Earnings Ratio (17x) compared to the South American Capital Markets industry average (9.5x).
Price to Earnings Ratio vs Fair Ratio
What is GS *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 17x |
| Fair PE Ratio | 17.3x |
Price-To-Earnings vs Fair Ratio: GS * is good value based on its Price-To-Earnings Ratio (17x) compared to the estimated Fair Price-To-Earnings Ratio (17.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | Mex$7,321.51 | Mex$7,586.95 +3.6% | 9.4% | Mex$8,485.07 | Mex$6,109.94 | n/a | 22 |
| Apr ’25 | Mex$6,910.75 | Mex$6,948.92 +0.6% | 8.3% | Mex$8,168.22 | Mex$5,881.78 | n/a | 22 |
| Mar ’25 | Mex$6,600.00 | Mex$7,091.32 +7.4% | 9.4% | Mex$8,661.71 | Mex$6,076.89 | n/a | 23 |
| Feb ’25 | Mex$6,585.00 | Mex$7,106.82 +7.9% | 10.1% | Mex$8,682.30 | Mex$5,576.58 | n/a | 22 |
| Jan ’25 | Mex$6,496.13 | Mex$6,508.32 +0.2% | 11.2% | Mex$8,171.52 | Mex$5,181.52 | n/a | 24 |
| Dec ’24 | Mex$5,965.00 | Mex$6,480.40 +8.6% | 10.9% | Mex$8,048.20 | Mex$5,245.09 | n/a | 24 |
| Nov ’24 | Mex$5,467.96 | Mex$6,869.19 +25.6% | 10.0% | Mex$8,119.35 | Mex$5,540.05 | n/a | 23 |
| Oct ’24 | Mex$5,699.10 | Mex$6,737.51 +18.2% | 9.1% | Mex$7,889.27 | Mex$5,347.17 | n/a | 23 |
| Sep ’24 | Mex$5,600.00 | Mex$6,599.47 +17.8% | 9.4% | Mex$7,879.09 | Mex$5,212.85 | n/a | 23 |
| Aug ’24 | Mex$5,990.53 | Mex$6,533.20 +9.1% | 9.8% | Mex$8,144.01 | Mex$5,142.70 | n/a | 23 |
| Jul ’24 | Mex$5,559.50 | Mex$6,634.99 +19.3% | 10.0% | Mex$8,042.64 | Mex$5,219.16 | n/a | 23 |
| Jun ’24 | Mex$5,597.91 | Mex$6,972.07 +24.5% | 9.1% | Mex$8,385.41 | Mex$5,887.63 | n/a | 23 |
| May ’24 | Mex$6,169.20 | Mex$7,045.17 +14.2% | 9.2% | Mex$8,478.99 | Mex$5,953.33 | n/a | 23 |
| Apr ’24 | Mex$5,880.20 | Mex$7,090.71 +20.6% | 10.4% | Mex$8,470.53 | Mex$5,947.39 | Mex$6,910.75 | 22 |
| Mar ’24 | Mex$6,281.00 | Mex$7,240.10 +15.3% | 11.0% | Mex$8,960.94 | Mex$5,973.96 | Mex$6,600.00 | 23 |
| Feb ’24 | Mex$6,862.76 | Mex$7,442.31 +8.4% | 10.5% | Mex$9,320.60 | Mex$6,213.74 | Mex$6,585.00 | 23 |
| Jan ’24 | Mex$6,665.00 | Mex$7,652.72 +14.8% | 11.3% | Mex$9,561.33 | Mex$5,830.08 | Mex$6,496.13 | 25 |
| Dec ’23 | Mex$7,347.25 | Mex$7,529.68 +2.5% | 12.1% | Mex$9,848.01 | Mex$5,770.32 | Mex$5,965.00 | 25 |
| Nov ’23 | Mex$6,850.00 | Mex$7,634.55 +11.5% | 11.8% | Mex$9,406.39 | Mex$5,718.77 | Mex$5,467.96 | 25 |
| Oct ’23 | Mex$5,819.41 | Mex$7,803.23 +34.1% | 12.5% | Mex$10,239.98 | Mex$5,871.46 | Mex$5,699.10 | 25 |
| Sep ’23 | Mex$6,680.00 | Mex$7,845.09 +17.4% | 12.4% | Mex$10,236.71 | Mex$6,177.08 | Mex$5,600.00 | 25 |
| Aug ’23 | Mex$6,700.00 | Mex$7,993.11 +19.3% | 12.2% | Mex$10,411.06 | Mex$6,282.29 | Mex$5,990.53 | 26 |
| Jul ’23 | Mex$5,975.00 | Mex$8,262.58 +38.3% | 11.6% | Mex$10,224.08 | Mex$6,498.87 | Mex$5,559.50 | 26 |
| Jun ’23 | Mex$6,265.00 | Mex$8,533.83 +36.2% | 11.5% | Mex$10,576.03 | Mex$6,466.86 | Mex$5,597.91 | 26 |
| May ’23 | Mex$6,420.22 | Mex$8,440.70 +31.5% | 12.5% | Mex$10,979.56 | Mex$6,346.75 | Mex$6,169.20 | 26 |
| Apr ’23 | Mex$6,543.80 | Mex$8,631.16 +31.9% | 11.4% | Mex$11,397.23 | Mex$7,048.81 | Mex$5,880.20 | 26 |
Analyst Forecast: Target price is less than 20% higher than the current share price.